AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34571181 — intervention group
Group type: EXPERIMENTAL
Intervention: HTO+P-PRP
Number of subjects: 80
Study 34571181 — intervention group
Group type: COMPARATOR
Intervention: HTO alone
Number of subjects: 80
Study 32379668 — intervention group
Group type: EXPERIMENTAL
Intervention: Benson relaxation technique (BRT), performed twice daily for 20 min over one month
Number of subjects: 65
Study 33342624 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 35034428 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-GLP-1 RA relay group (mean 16.8 ± 11.4 IU/day for 12 weeks, then liraglutide for 12 weeks)
Number of subjects: 0
Study 35034428 — intervention group
Group type: COMPARATOR
Intervention: GLP-1 RA first group (liraglutide 0.9 mg for 24 weeks)
Number of subjects: 0
Study 32844904 — intervention group
Group type: EXPERIMENTAL
Intervention: Bt cotton expressing Cry1F and Cry1Ac proteins
Number of subjects: 40
Study 32844904 — intervention group
Group type: COMPARATOR
Intervention: Isohybrid cotton
Number of subjects: 40
Study 36002047 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter edge‐to‐edge repair (TEER)
Number of subjects: 144
Study 36002047 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 144
Study 33766513 — intervention group
Group type: EXPERIMENTAL
Intervention: Tokuyama bond force II™
Number of subjects: 270
Study 33766513 — intervention group
Group type: EXPERIMENTAL
Intervention: Scotchbond Universal™
Number of subjects: 270
Study 33766513 — intervention group
Group type: COMPARATOR
Intervention: Positive control group
Number of subjects: 270
Study 32740512 — intervention group
Group type: EXPERIMENTAL
Intervention: IV Dexmedetomidine 0.6 microgram/kg 30 minutes preoperatively
Number of subjects: 12
Study 35820444 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated systemic fibrinolytic therapy (FT) with 100 mg t-PA in 2 hours
Number of subjects: 0
Study 35820444 — intervention group
Group type: COMPARATOR
Intervention: Full-dose systemic fibrinolysis
Number of subjects: 0
Study 33526167 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlamydia education and training program for general practice nurses
Number of subjects: 0
Study 33526167 — intervention group
Group type: COMPARATOR
Intervention: No training for general practice nurses
Number of subjects: 0
Study 33136819 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer change agent Type I network intervention with opinion leader workshop and telephonic booster sessions
Number of subjects: 423
Study 33136819 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer change agent Type I network intervention
Number of subjects: 423
Study 33136819 — intervention group
Group type: COMPARATOR
Intervention: Time-matched control
Number of subjects: 423
Study 33327936 — intervention group
Group type: EXPERIMENTAL
Intervention: Early foster care intervention (randomized controlled trial)
Number of subjects: 3471
Study 33327936 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of childhood exposure to institutional care
Number of subjects: 3471
Study 33327936 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial deprivation in US families
Number of subjects: 3471
Study 33327936 — intervention group
Group type: COMPARATOR
Intervention: Never institutionalized counterparts
Number of subjects: 3471
Study 36360914 — intervention group
Group type: EXPERIMENTAL
Intervention: Theacrine supplementation
Number of subjects: 22
Study 36360914 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 34328444 — intervention group
Group type: EXPERIMENTAL
Intervention: Data model based on FHIR standard
Number of subjects: 1200
Study 34328444 — intervention group
Group type: EXPERIMENTAL
Intervention: Topic modeling analysis
Number of subjects: 1200
Study 32300129 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation online session
Number of subjects: 326
Study 32300129 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 326
Study 35799408 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic Spine Manipulation (TSM)
Number of subjects: 26
Study 35799408 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic Spine Mobility Exercises (TSME)
Number of subjects: 26
Study 35799408 — intervention group
Group type: EXPERIMENTAL
Intervention: TSME
Number of subjects: 26
Study 35799408 — intervention group
Group type: COMPARATOR
Intervention: TSM
Number of subjects: 26
Study 32769832 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized Education Plan (IEP) services
Number of subjects: 74
Study 32769832 — intervention group
Group type: COMPARATOR
Intervention: Informal or no services
Number of subjects: 74
Study 32769832 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex (male)
Number of subjects: 74
Study 32769832 — intervention group
Group type: EXPERIMENTAL
Intervention: Severity of TBI (severe)
Number of subjects: 74
Study 32769832 — intervention group
Group type: EXPERIMENTAL
Intervention: Domain-specific concerns reported by parents
Number of subjects: 74
Study 32769832 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex (female)
Number of subjects: 74
Study 32769832 — intervention group
Group type: EXPERIMENTAL
Intervention: Less severe or less visible deficits
Number of subjects: 74
Study 32310145 — intervention group
Group type: EXPERIMENTAL
Intervention: VIH‐TAVIE (web-based intervention)
Number of subjects: 88
Study 32310145 — intervention group
Group type: COMPARATOR
Intervention: Websites (control group)
Number of subjects: 88
Study 36389110 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on the theory of planned behaviour; one-hour lecture session supported by audio-video materials for PA promotion
Number of subjects: 126
Study 36389110 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 126
Study 32223649 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacituzumab govitecan (SG)
Number of subjects: 0
Study 32223649 — intervention group
Group type: COMPARATOR
Intervention: Treatment of physician's choice
Number of subjects: 0
Study 35094962 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive nonvalidated questionnaire on smoking in relation to bladder cancer
Number of subjects: 370
Study 34456270 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccinated group (HPV vaccination)
Number of subjects: 331
Study 34456270 — intervention group
Group type: COMPARATOR
Intervention: Nonvaccinated group (no HPV vaccination)
Number of subjects: 331
Study 34456270 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 331
Study 34242256 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile text messages related to cancer risk factors once a day for two months
Number of subjects: 0
Study 34242256 — intervention group
Group type: COMPARATOR
Intervention: General health messages daily for two months
Number of subjects: 0
Study 616517401 — intervention group
Group type: EXPERIMENTAL
Intervention: HESWO
Number of subjects: 12
Study 616517401 — intervention group
Group type: COMPARATOR
Intervention: RGO
Number of subjects: 12
Study 35025824 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior oriented psychological intervention
Number of subjects: 48
Study 35025824 — intervention group
Group type: COMPARATOR
Intervention: Fractional photothermolysis
Number of subjects: 48
Study 34114691 — intervention group
Group type: EXPERIMENTAL
Intervention: AUC-targeted therapeutic drug monitoring (TDM)
Number of subjects: 40
Study 34114691 — intervention group
Group type: COMPARATOR
Intervention: Ctrough-targeted TDM
Number of subjects: 40
Study 34114691 — intervention group
Group type: EXPERIMENTAL
Intervention: AUC-targeted TDM
Number of subjects: 40
Study 33448906 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 oz/d almond
Number of subjects: 60
Study 33448906 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 oz/d almond
Number of subjects: 60
Study 33448906 — intervention group
Group type: COMPARATOR
Intervention: 3.5 oz/d snack (control)
Number of subjects: 60
Study 32406699 — intervention group
Group type: EXPERIMENTAL
Intervention: Queer People of Color Identity Affirmation Scale (QPIAS)
Number of subjects: 703
Study 34847589 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-velocity concentric resistance training (10 weeks)
Number of subjects: 30
Study 34847589 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study 33203542 — intervention group
Group type: EXPERIMENTAL
Intervention: SEEK training and implementation
Number of subjects: 924
Study 33203542 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 924
Study 35354647 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory care management
Number of subjects: 236
Study 35354647 — intervention group
Group type: COMPARATOR
Intervention: Standard guideline-based management
Number of subjects: 236
Study 34569167 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate (150 mg once monthly)
Number of subjects: 24
Study 34569167 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 32719133 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiments involving randomization of policies or treatments
Number of subjects: 1955
Study 32719133 — intervention group
Group type: COMPARATOR
Intervention: Approval of policies or treatments
Number of subjects: 1955
Study 34746964 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured interview
Number of subjects: 0
Study 34746964 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-assessment
Number of subjects: 0
Study 34746964 — intervention group
Group type: COMPARATOR
Intervention: Physician assessment
Number of subjects: 0
Study 32744395 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec (IDeg)
Number of subjects: 46
Study 32744395 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine U300 (IGlarU300)
Number of subjects: 46
Study 35124626 — intervention group
Group type: EXPERIMENTAL
Intervention: Motion style acupuncture therapy (MSAT) combined with conventional acupuncture therapy (CAT)
Number of subjects: 76
Study 35124626 — intervention group
Group type: COMPARATOR
Intervention: Conventional acupuncture therapy (CAT)
Number of subjects: 76
Study 33548422 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed incision negative pressure therapy (ciNPT)
Number of subjects: 242
Study 33548422 — intervention group
Group type: COMPARATOR
Intervention: Standard gauze
Number of subjects: 242
Study 32904701 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 71
Study 32904701 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 32904701 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol (in COPD patients with severe airflow limitation)
Number of subjects: 71
Study 32904701 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in COPD patients with severe airflow limitation)
Number of subjects: 71
Study 35752582 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefapixant 15 mg BID
Number of subjects: 169
Study 35752582 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefapixant 45 mg BID
Number of subjects: 169
Study 32118753 — intervention group
Group type: EXPERIMENTAL
Intervention: Shi's Yi-Qi Bu-Shen Tong-Luo decoction (BTD) combined with wrist manipulation
Number of subjects: 80
Study 32118753 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 36116385 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossword and word search puzzles used as a teaching technique; applied over four weeks during the semester.
Number of subjects: 96
Study 36116385 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative feedback from focus group discussions.
Number of subjects: 96
Study 32272623 — intervention group
Group type: EXPERIMENTAL
Intervention: Solution-focused group counseling intervention for five weeks
Number of subjects: 18
Study 32272623 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 18
Study 36049494 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline supplemented with pregabalin
Number of subjects: 0
Study 36049494 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin supplemented with amitriptyline
Number of subjects: 0
Study 36049494 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine supplemented with pregabalin
Number of subjects: 0
Study 33960181 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sensorimotor stimulation (20 minutes before conventional therapy)
Number of subjects: 71
Study 33960181 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy (90 minutes, five times/week for four months)
Number of subjects: 71
Study 33960181 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sensorimotor stimulation
Number of subjects: 71
Study 33960181 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy
Number of subjects: 71
Study 32807209 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg orally daily for 14 days
Number of subjects: 0
Study 32807209 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 35622090 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcutaneous spinal direct current stimulation (tsDCS)
Number of subjects: 15
Study 35622090 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 15
Study 32036406 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 45
Study 32036406 — intervention group
Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 45
Study 32036406 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study 32036406 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including TENS, placebo, and control)
Number of subjects: 45
Study 36026988 — intervention group
Group type: EXPERIMENTAL
Intervention: SHEPP intervention
Number of subjects: 982
Study 36026988 — intervention group
Group type: COMPARATOR
Intervention: Routine Activity school
Number of subjects: 982
Study 33888314 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (15 mg/kg, maximum 1 g)
Number of subjects: 50
Study 33888314 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 32702212 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 300
Study 32286247 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga training for 12 weeks, 1 hour each morning
Number of subjects: 66
Study 32286247 — intervention group
Group type: COMPARATOR
Intervention: No yoga training (Control)
Number of subjects: 66
Study 36018547 — intervention group
Group type: EXPERIMENTAL
Intervention: Camel milk
Number of subjects: 60
Study 33340316 — intervention group
Group type: EXPERIMENTAL
Intervention: Baloxavir (40/80 mg single dose based on weight)
Number of subjects: 117
Study 33340316 — intervention group
Group type: EXPERIMENTAL
Intervention: Baloxavir
Number of subjects: 117
Study 33340316 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study 36412085 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting overall survival (OS)
Number of subjects: 22368
Study 36412085 — intervention group
Group type: COMPARATOR
Intervention: Low-risk group
Number of subjects: 22368
Study 33612637 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding
Number of subjects: 112
Study 33612637 — intervention group
Group type: COMPARATOR
Intervention: Non-exclusive breastfeeding
Number of subjects: 112
Study 36083194 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-Based Capillary Refill Time (VB-CRT) assessment
Number of subjects: 99
Study 36083194 — intervention group
Group type: COMPARATOR
Intervention: Bedside Capillary Refill Time (CRT) assessment
Number of subjects: 99
Study 33158839 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute Stress of Health Professionals Caring COVID‐19 Scale (EASE)
Number of subjects: 685
Study 33158839 — intervention group
Group type: COMPARATOR
Intervention: Territory affected by COVID-19
Number of subjects: 685
Study 33158839 — intervention group
Group type: COMPARATOR
Intervention: Evolutionary stage of the COVID-19 outbreak
Number of subjects: 685
Study 36073362 — intervention group
Group type: EXPERIMENTAL
Intervention: Tribulus terrestris L.
Number of subjects: 13
Study 36073362 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 33446159 — intervention group
Group type: EXPERIMENTAL
Intervention: Velocity-specific exercise (VSE)
Number of subjects: 30
Study 33446159 — intervention group
Group type: COMPARATOR
Intervention: Isometric exercise (IE)
Number of subjects: 30
Study 32227772 — intervention group
Group type: EXPERIMENTAL
Intervention: Xinglou Chengqi (XLCQ) decoction
Number of subjects: 317
Study 32227772 — intervention group
Group type: COMPARATOR
Intervention: Clysis therapy using glycerin enemas or lactulose oral solution (Control)
Number of subjects: 317
Study 35074417 — intervention group
Group type: EXPERIMENTAL
Intervention: Leaflet resection
Number of subjects: 104
Study 35074417 — intervention group
Group type: COMPARATOR
Intervention: Leaflet preservation
Number of subjects: 104
Study 33491437 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal serum 25(OH)-vitamin D3 levels
Number of subjects: 539
Study 33290437 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed-onset muscle soreness (DOMS) intervention (n = 20)
Number of subjects: 50
Study 33290437 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve growth factor (NGF) injection (n = 20)
Number of subjects: 50
Study 33290437 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 10)
Number of subjects: 50
Study 35734655 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined locomotor training and aerobic exercise (3 times/week, progressive increase in sets and repetitions)
Number of subjects: 20
Study 35734655 — intervention group
Group type: COMPARATOR
Intervention: Aerobic exercise (7 times/week for 30 min/session)
Number of subjects: 20
Study 32162931 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 97
Study 34280916 — intervention group
Group type: EXPERIMENTAL
Intervention: DP-SCIT for 1 year
Number of subjects: 307
Study 34280916 — intervention group
Group type: COMPARATOR
Intervention: Symptomatic treatment
Number of subjects: 307
Study 33317540 — intervention group
Group type: EXPERIMENTAL
Intervention: Marriage at/after age 18
Number of subjects: 1278
Study 33317540 — intervention group
Group type: COMPARATOR
Intervention: Child-brides (married below age 18)
Number of subjects: 1278
Study 34402980 — intervention group
Group type: EXPERIMENTAL
Intervention: Random-hatching (LR)
Number of subjects: 160
Study 34402980 — intervention group
Group type: COMPARATOR
Intervention: Negative control (NC)
Number of subjects: 160
Study 34402980 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandblasting with Al2O3 (SB)
Number of subjects: 160
Study 34402980 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossed-lines (LC)
Number of subjects: 160
Study 34402980 — intervention group
Group type: EXPERIMENTAL
Intervention: Parallel-waves (LW)
Number of subjects: 160
Study 32943389 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG plus corticosteroids
Number of subjects: 210
Study 32943389 — intervention group
Group type: COMPARATOR
Intervention: IVIG
Number of subjects: 210
Study 36286979 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg 1 time per day + Alfasoxx 1 sachet qid (intervention group)
Number of subjects: 81
Study 36286979 — intervention group
Group type: COMPARATOR
Intervention: Pantoprazole 40 mg 1 time per day (control group)
Number of subjects: 81
Study 36286979 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (intervention group)
Number of subjects: 81
Study 36286979 — intervention group
Group type: COMPARATOR
Intervention: Standard PPI monotherapy (control group)
Number of subjects: 81
Study 33170378 — intervention group
Group type: EXPERIMENTAL
Intervention: l-Carnosine (10–15 mg/kg in 2 divided doses) plus standard care (occupational and speech therapy)
Number of subjects: 67
Study 33170378 — intervention group
Group type: COMPARATOR
Intervention: Standard care (occupational and speech therapy)
Number of subjects: 67
Study 33652243 — intervention group
Group type: EXPERIMENTAL
Intervention: Digestible lysine levels (0.714, 0.816, 0.918, 1.020, and 1.122%)
Number of subjects: 500
Study 35078510 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative endoluminal pyloromyotomy
Number of subjects: 128
Study 35078510 — intervention group
Group type: COMPARATOR
Intervention: Atraumatic stretching of the pylorus
Number of subjects: 128
Study 34062866 — intervention group
Group type: COMPARATOR
Intervention: Novel method using random forest for classification based on fusion features from gene sequence and subregions correlation.
Number of subjects: 0
Study 34062866 — intervention group
Group type: COMPARATOR
Intervention: Hippocampal subregions and genes such as HATA, fimbria, parasubiculum, RYR3, and PRKCE.
Number of subjects: 0
Study 36446797 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive assisted locomotion training (LOC)
Number of subjects: 8
Study 36446797 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurorehabilitation protocol integrating assisted locomotion with a noninvasive brain-machine interface (L + BMI)
Number of subjects: 8
Study 36446797 — intervention group
Group type: COMPARATOR
Intervention: L + BMI group
Number of subjects: 8
Study 33353506 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual massage
Number of subjects: 17
Study 33353506 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle energy
Number of subjects: 17
Study 33353506 — intervention group
Group type: COMPARATOR
Intervention: Rest control activity
Number of subjects: 17
Study 35248015 — intervention group
Group type: EXPERIMENTAL
Intervention: CUIDA-TE APP (2-month EMI group, n≥58)
Number of subjects: 174
Study 35248015 — intervention group
Group type: EXPERIMENTAL
Intervention: MONITOR EMOCIONAL APP (2-month EMA only group, n≥58)
Number of subjects: 174
Study 35248015 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (n≥58)
Number of subjects: 174
Study 33964828 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined eradication and prokinetic therapy (itoprid hydrochloride 50 mg three times a day)
Number of subjects: 126
Study 33964828 — intervention group
Group type: COMPARATOR
Intervention: Eradication therapy only
Number of subjects: 126
Study 34432984 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (ICBT) for tinnitus
Number of subjects: 27